Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Product Information Leaflets 31 - 60 of 203
<  Previous 30    |  1  2  3  4  5  6  7  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
SPC	Itsehoito	Ibusal 200 mg, 400 mg tabletti, kalvopäällysteinen PL 2024-06-12 OTC
SPC	Resepti	Ibusal 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen PL 2024-06-12
SPC	Itsehoito	Ibutabs 400 mg tabletti, kalvopäällysteinen PL 2024-06-12
SPC	Resepti	Ibuver 400 mg tabletti, kalvopäällysteinen PL 2024-01-17
SPC	Itsehoito	Ibuver 400 mg tabletti, kalvopäällysteinen PL OTC 2024-01-17
SPC	Itsehoito	Ibuxin 20 mg - ml siirappi PL 2024-06-03 OTC
SPC	Resepti	Ibuxin 40 mg - ml siirappi PL 2024-06-03
SPC	Itsehoito	Ibuxin 40 mg - ml siirappi PL 2024-06-03 OTC
SPC	Itsehoito	Ibuxin 400 mg jauhe PL 2024-03-11
SPC	Itsehoito	Ibuxin 400 mg tabletti, kalvopäällysteinen PL 2024-01-22 OTC
SPC	Resepti	Ibuxin 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen PL 2024-01-22
SPC	Resepti	Ibuxin 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2020-08-20
SPC	Resepti	Ibuxin rapid 400 mg tabletti kalvopäällysteinen PL 2024-02-08
SPC	Itsehoito	Ibuxin rapid 400 mg tabletti kalvopäällysteinen PL 2024-02-08 OTC
SPC	Itsehoito	Ibuxin-Caps 400 mg kapseli, pehmeä PL 2024-04-09
SPC	Resepti	Icalziss 340 mmol-l infuusioneste, liuos PL 2024-11-21
		European Medicines Agency's website: Icandra (ent. Vildagliptin/Metformin Hydrochloride Novartis) - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Icatibant Accord - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Icatibant Aguettant 30 mg injektioneste, liuos esitäytetty ruisku PL 2023-02-28
SPC	Resepti	Icatibant Avansor 30 mg injektioneste, liuos PL 2021-10-29
SPC	Resepti	Icatibant Fresenius 30 mg injektioneste, liuos, esitäytetty ruisku PL 2024-04-23
SPC	Resepti	Icatibant Glenmark 30 mg injektioneste, liuos esitäytetty ruisku PL 2021-11-03
SPC	Resepti	Icatibant ratiopharm 30 mg injektioneste, liuos, esitäytetty ruisku PL 2024-01-05
SPC	Resepti	Icatibant Sandoz 30 mg injektioneste, liuos esitäytetty ruisku PL 2024-05-10
SPC	Resepti	Icatibant Stada 30 mg-3 ml injektioneste liuos PL 2021-11-01
SPC	Resepti	Icatibant Universal Farma 30 mg injektioneste, liuos esitäytetty ruisku PL 2024-04-26
SPC	Resepti	Icatibant Viatris 30 mg liuos esitäytetty ruisku PL 2024-07-23
SPC	Resepti	Icatibant Zentiva 30 mg, injektioneste, liuos esitäytetyssä ruiskussa, PL 2021-11-03
		European Medicines Agency's website: Iclusig - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Icomas 0.30 % lääkkeellinen kaasu, puristettu PL 2021-12-30
<  Previous 30    |  1  2  3  4  5  6  7  |  Next 30   >